首页> 外文期刊>Pathology oncology research: POR >Label-Free Semiquantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics Analysis of Laryngeal/Hypopharyngeal Squamous Cell Carcinoma on Formalin-Fixed, Paraffin-Embedded Tissue Samples - a Pilot Study
【24h】

Label-Free Semiquantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics Analysis of Laryngeal/Hypopharyngeal Squamous Cell Carcinoma on Formalin-Fixed, Paraffin-Embedded Tissue Samples - a Pilot Study

机译:无标记的半定量液相色谱 - 淋式质谱蛋白质谱蛋白质癌癌甲醛固定,石蜡嵌入式组织样本 - 试验研究

获取原文
           

摘要

Squamous cell carcinoma (SCC) of the head and neck region is the sixth most frequent malignancy with high mortality rate. Due to its poor prognosis it is considered a growing public health problem worldwide inspite of existing treatment modalities. Thus, early diagnosis of new diseases and recurrences is emerging on one hand, but on the other hand troublesome in the lack of reliable tumor markers in this field. The rapid development of proteomics has opened new perspectives in tumor marker discovery. Liquid chromatography/mass spectrometry (LC/MS) as the gold standard in proteomics enables the semi-quantitative analysis of proteins within various tissues. Abundance differences between tumor and normal tissue also can be interpreted as tumor specific changes. The aim of this study was to identify potential tumor markers of laryngeal/hypopharyngeal SCC by revealing abundance changes between cancerous and the surrounding phenotypically healthy tissue. After separating the phenotypically cancerous and healthy parts of formalin-fixed paraffin-embedded tissues, each sample underwent protein recovery process and tryptic digestion for label-free semi-quantitative LC/MS analysis. Eight proteins showed significantly higher abundance in tumor including tenascin, transmembrane emp24 domain-containing protein 2, cytoplasmic dynein light chain 1, coactosin-like protein, small proline-rich protein 2D, nucleolin, U5 small nuclear RNP 200-kDa helicase and fatty aldehyde dehydrogenase. Desmoglein-1 and keratin type I cytoskeletal 9 were down-regulated in tumor. Using Ingenuity Pathway Analysis we mapped the signaling pathways these proteins play role in regarding other tumors. Based on these findings these proteins may serve as promising biomarkers in the fight against laryngeal/hypopharyngeal SCCs.
机译:头部和颈部区域的鳞状细胞癌(SCC)是最常见的恶性肿瘤,死亡率高。由于其预后不良,它被认为是全球越来越多的公共卫生问题,全球存在现有的治疗方式。因此,一方面涌现了新疾病和复发的早期诊断,但另一方面在这一领域缺乏可靠的肿瘤标志物中的困扰。蛋白质组学的快速发展在肿瘤标志物发现中开辟了新的视角。液相色谱/质谱(LC / MS)作为蛋白质组学中的金标准使得各种组织内的蛋白质的半定量分析能够。肿瘤和正常组织之间的丰富差异也可以解释为肿瘤特异性变化。本研究的目的是通过揭示癌症和周围的表型健康组织之间的丰度变化来识别喉/白血病SCC的潜在肿瘤标志物。分离成型固定石蜡包埋组织的表型癌症和健康部位后,每个样品接受蛋白质回收过程和对无标签半定量LC / MS分析的胰蛋白酶消化。八个蛋白质在肿瘤中显示出明显较高的肿瘤,包括TenAscin,跨膜EMP24结构域蛋白2,细胞质Dynein轻链1,Coactosin样蛋白,富含脯氨酸蛋白2D,核仁,U5小核RNP 200-KDA Helicase和脂肪醛脱氢酶。 Desmoglein-1和角蛋白类型I细胞骨骼9在肿瘤中下调。使用熟智能途径分析我们映射了这些蛋白质在其他肿瘤中起作用的信号通路。基于这些发现,这些蛋白质可以作为对抗喉/下咽SCC的斗争中有前途的生物标志物。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号